Ihara H - Search Results

1

Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors.

Sakata H, Matsubayashi K, Ihara H, Sato S, Kato T, Wakisaka A, Tadokoro K, Yu MY, Baylis SA, Ikeda H, Takamoto S. Sakata H, et al. Among authors: ihara h. Transfusion. 2013 Oct;53(10 Pt 2):2556-66. doi: 10.1111/j.1537-2995.2012.03949.x. Epub 2012 Nov 12. Transfusion. 2013. PMID: 23145866

2

Efficiency of donor screening for human parvovirus B19 by the receptor-mediated hemagglutination assay method.

Sakata H, Ihara H, Sato S, Kato T, Ikeda H, Sekiguchi S. Sakata H, et al. Among authors: ihara h. Vox Sang. 1999;77(4):197-203. doi: 10.1159/000031127. Vox Sang. 1999. PMID: 10717598

3

Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assay.

Sato S, Ohhashi W, Ihara H, Sakaya S, Kato T, Ikeda H. Sato S, et al. Among authors: ihara h. Transfusion. 2001 Sep;41(9):1107-13. doi: 10.1046/j.1537-2995.2001.41091107.x. Transfusion. 2001. PMID: 11552066

4

Efficacy of HBV NAT of pooled donor samples.

Sato S, Ohhashi W, Ihara H, Sakaya S, Kato T, Ikeda H. Sato S, et al. Among authors: ihara h. Transfusion. 2002 May;42(5):660. doi: 10.1046/j.1537-2995.2002.00142.x. Transfusion. 2002. PMID: 12084178 No abstract available.

5

Removal of parvovirus B19 from hemoglobin solution by nanofiltration.

Abe H, Sugawara H, Hirayama J, Ihara H, Kato T, Ikeda H, Ikebuchi K. Abe H, et al. Among authors: ihara h. Artif Cells Blood Substit Immobil Biotechnol. 2000 Sep;28(5):375-83. doi: 10.3109/10731190009118582. Artif Cells Blood Substit Immobil Biotechnol. 2000. PMID: 11009110

6

A human monoclonal antibody to high-frequency red cell antigen Jra.

Miyazaki T, Kwon KW, Yamamoto K, Tone Y, Ihara H, Kato T, Ikeda H, Sekiguchi S. Miyazaki T, et al. Among authors: ihara h. Vox Sang. 1994;66(1):51-4. doi: 10.1111/j.1423-0410.1994.tb00277.x. Vox Sang. 1994. PMID: 8146983

7

Interaction between desialylated hepatitis B virus and asialoglycoprotein receptor on hepatocytes may be indispensable for viral binding and entry.

Owada T, Matsubayashi K, Sakata H, Ihara H, Sato S, Ikebuchi K, Kato T, Azuma H, Ikeda H. Owada T, et al. Among authors: ihara h. J Viral Hepat. 2006 Jan;13(1):11-8. doi: 10.1111/j.1365-2893.2005.00648.x. J Viral Hepat. 2006. PMID: 16364077

8

Epidemiology of GBV-C in Japan.

Shimoyama R, Ihara H, Sato S, Kato T, Sekiguchi S. Shimoyama R, et al. Among authors: ihara h. Vox Sang. 1997;73(3):190. doi: 10.1046/j.1423-0410.2000.73301892.x. Vox Sang. 1997. PMID: 9358624 No abstract available.

9

Virus trap in human serum albumin nanotube.

Komatsu T, Qu X, Ihara H, Fujihara M, Azuma H, Ikeda H. Komatsu T, et al. Among authors: ihara h. J Am Chem Soc. 2011 Mar 16;133(10):3246-8. doi: 10.1021/ja1096122. Epub 2011 Feb 22. J Am Chem Soc. 2011. PMID: 21341767

10

Human genes for prostaglandin endoperoxide synthase-2, thromboxane synthase and prostacyclin synthase.

Tanabe T, Miyata A, Nanayama T, Tone Y, Ihara H, Toh H, Takahashi E, Ullrich V. Tanabe T, et al. Among authors: ihara h. Adv Prostaglandin Thromboxane Leukot Res. 1995;23:133-5. Adv Prostaglandin Thromboxane Leukot Res. 1995. PMID: 7732818 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

668 results

Search Page

Filters